Table 1.
Characteristic | Number (n = 63) | Percentage (%) |
---|---|---|
Age, Median (IQR) | 31 (28, 37) | |
Sex | ||
Female | 37 | 58.7 |
Male | 26 | 41.3 |
Baseline CD4 cell count, Median (IQR) | 284 (158, 518) | |
Level of education | ||
Primary | 33 | 52.4 |
Secondary | 26 | 41.3 |
Tertiary | 4 | 6.3 |
Religion | ||
Christian | 49 | 77.8 |
Muslim | 14 | 22.2 |
Residence | ||
Rural | 1 | 1.6 |
Urban | 62 | 98.4 |
Employment | ||
No | 9 | 14.3 |
Yes | 54 | 85.7 |
Marital status | ||
Single | 33 | 52.4 |
Married | 30 | 47.6 |
Tuberculosis status at baseline | ||
No symptoms | 52 | 82.5 |
TB suspect | 10 | 15.9 |
TB disease | 1 | 1.6 |
Baseline blood pressure | ||
Normal BP | 52 | 82.5 |
Pre-hypertension | 8 | 12.7 |
Hypertension | 3 | 4.8 |
HIV clinical stage | ||
Stage 1 | 61 | 96.8 |
Stage 2 | 1 | 1.6 |
Stage 3 | 1 | 1.6 |
Body Mass Index (BMI) | ||
Underweight (< 18.5) | 7 | 11.1 |
Normal (18.5–24.9) | 41 | 65.1 |
Overweight (25.0-29.9) | 14 | 22.2 |
Obese (≥ 30) | 1 | 1.6 |
Waist circumference | ||
Normal | 44 | 69.8 |
Increased risk of cardiometabolic complications | 10 | 15.9 |
Substantially increased risk of cardiometabolic complications | 9 | 14.3 |
Smoking status | ||
Smoker | 6 | 9.5 |
Non-smoker | 57 | 90.5 |
Physical activity | ||
GPAQ < 600 MET minutes | 8 | 12.7 |
GPAQ ≥ 600 MET minutes | 55 | 87.3 |
Alcohol consumption | ||
No consumption | 33 | 52.4 |
Low risk alcohol consumption | 19 | 30.2 |
Hazardous alcohol consumption | 6 | 9.5 |
Risk of alcohol dependence | 5 | 7.9 |
24-week viral loads (Proxy baseline VL), n = 62 | ||
Virologically suppressed | 63 | 100 |
Anti-GAD antibody | ||
Negative | 63 | 100 |
Anti-IA2 antibody status | ||
Negative | 61 | 96.8 |
Positive | 2 | 3.2 |
Laboratory investigations, Median (IQR) | ||
Creatinine (mg/dl) | 0.86 (0.77, 0.98) | |
LDL (mg/dl) | 75.2 (53.8, 90.3) | |
HDL (mg/dl) | 29.6 (24.9, 35.8) | |
Total cholesterol (mg/dl) | 130.9 (111.2, 158.7) | |
Triglycerides (mg/dl) | 95.2 (71.3, 124.0) |
IQR- interquartile range, BP- blood pressure, GPAQ- Global physical activity questionnaire, MET- metabolic equivalent, anti- GAD- anti- glutamic acid decarboxylase, anti- IA2 - anti- Islet cell antigen-2, LDL- low density lipoproteins, HDL- high density lipoproteins.